CorMedix
CRMD
#7712
Rank
A$0.63 B
Marketcap
A$7.96
Share price
3.74%
Change (1 day)
-46.88%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2026 (TTM): A$0.30 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.45 Billion. In 2025 the company made an earning of A$0.22 Billion, an increase over its 2024 earnings that were of -A$29.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.30 B32.47%
2025 A$0.22 B-876.29%
2024 -A$29.2 Million-58.3%
2023 -A$70.01 Million53%
2022 -A$45.76 Million2.81%
2021 -A$44.51 Million8.32%
2020 -A$41.09 Million26.53%
2019 -A$32.48 Million-19.89%
2018 -A$40.54 Million-18.72%
2017 -A$49.88 Million34.56%
2016 -A$37.07 Million34.88%
2015 -A$27.48 Million-11.08%
2014 -A$30.91 Million124.69%
2013 -A$13.76 Million144.91%
2012 -A$5.62 Million-48.41%
2011 -A$10.89 Million-33.29%
2010 -A$16.32 Million78.42%
2009 -A$9.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.26 B 635.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$19.46 M-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.3 Billion-195.67%๐Ÿ‡บ๐Ÿ‡ธ USA